{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:55:50Z","timestamp":1781740550910,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K07436"],"award-info":[{"award-number":["23K07436"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJCE1310"],"award-info":[{"award-number":["JPMJCE1310"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016264","name":"Center for Medical Research and Education, Osaka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrep.2026.102552","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:22:11Z","timestamp":1773814931000},"page":"102552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Silicon-based agent mitigates fatty liver formation in a CDAHFD60-induced MASH mouse model by enhancing hepatic function"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3965-0716","authenticated-orcid":false,"given":"Yoshihisa","family":"Koyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuei","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2026.102552_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrep.2026.102552_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrep.2026.102552_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrep.2026.102552_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrep.2026.102552_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1179\/1351000213Y.0000000050","article-title":"The relationship between oxidative stress and nonalcoholic fatty liver disease: its effects on the development of nonalcoholic steatohepatitis","volume":"18","author":"Ucar","year":"2013","journal-title":"Redox Rep."},{"key":"10.1016\/j.bbrep.2026.102552_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6889533","article-title":"The role and mechanism of oxidative stress and nuclear receptors in the development of NAFLD","author":"Hong","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrep.2026.102552_bib7","doi-asserted-by":"crossref","first-page":"G400","DOI":"10.1152\/ajpgi.00121.2020","article-title":"Mitochondrial oxidative injury: a key player in nonalcoholic fatty liver disease","volume":"319","author":"Dornas","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbrep.2026.102552_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11051-017-3873-z","article-title":"Hydrogen generation by reaction of Si nanopowder with neutral water","volume":"19","author":"Kobayashi","year":"2017","journal-title":"J. Nano Res."},{"key":"10.1016\/j.bbrep.2026.102552_bib9","doi-asserted-by":"crossref","first-page":"9634","DOI":"10.1038\/s41598-022-13655-7","article-title":"A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent","volume":"12","author":"Koyama","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2026.102552_bib10","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1038\/s41598-020-62755-9","article-title":"Renoprotective and neuroprotective effects of enteric hydrogen generation from Si-based agent","volume":"10","author":"Kobayashi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2026.102552_bib11","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1038\/s41598-023-32745-8","article-title":"Effect of the new silicon-based agent on the symptoms of interstitial pneumonitis","volume":"13","author":"Shimada","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2026.102552_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bbrep.2026.102552_bib13","first-page":"57","article-title":"Pathological analysis of age-related bladder dysfunction","volume":"49","author":"Nakatsukasa","year":"2023","journal-title":"Kawasaki Med. J."},{"key":"10.1016\/j.bbrep.2026.102552_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis","volume":"52","author":"Rolo","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrep.2026.102552_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11010091","article-title":"Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease","volume":"11","author":"Ma","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrep.2026.102552_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/10715762.2013.837577","article-title":"Involvement of free radicals and oxidative stress in NAFLD\/NASH","volume":"47","author":"Sumida","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbrep.2026.102552_bib17","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1478-3231.2011.02604.x","article-title":"Antioxidants as therapeutic agents for liver disease","volume":"31","author":"Singal","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.bbrep.2026.102552_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7019573","article-title":"Treatment of NASH with antioxidant therapy: beneficial effect of red cabbage on type 2 diabetic rats","author":"Dal","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrep.2026.102552_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3389\/fphar.2020.00483","article-title":"Hepatoprotective and anti-oxidative effects of total flavonoids from Qu zhi qiao (fruit of citrus paradisi cv.Changshanhuyou) on nonalcoholic steatohepatitis","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102552_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1423-0127-19-26","article-title":"Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn-salen complexes via reduction of oxidative stress","volume":"19","author":"Rezazadeh","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbrep.2026.102552_bib21a","article-title":"Antioxidant therapy in nonalcoholic steatohepatitis","author":"Al-Busafi","year":"2012","journal-title":"Hepat Res Treat"},{"key":"10.1016\/j.bbrep.2026.102552_bib21b","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1227046","article-title":"NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials","volume":"10","author":"Hegazi","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrep.2026.102552_bib22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nm1577","article-title":"Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals","volume":"13","author":"Ohsawa","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrep.2026.102552_bib23","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.25782","article-title":"Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice","volume":"56","author":"Kawai","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrep.2026.102552_bib24","doi-asserted-by":"crossref","first-page":"G450","DOI":"10.1152\/ajpgi.00158.2020","article-title":"Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and sirt 1 signaling","volume":"320","author":"Li","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbrep.2026.102552_bib25","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.3748\/wjg.v24.i45.5095","article-title":"Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse model","volume":"24","author":"Jackson","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrep.2026.102552_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11101935","article-title":"Biological effects of hydrogen water on subjects with NAFLD: a randomized, placebo-controlled trial","volume":"11","author":"Kura","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrep.2026.102552_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000200","article-title":"Experimental models of fatty liver diseases: status and appraisal","volume":"7","author":"Wang","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.bbrep.2026.102552_bib28","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1248\/bpb.b19-00338","article-title":"Reduced serum cholesterol and triglyceride levels in a choline-deficient L-Amino acid-defined high-fat diet (CDAHFD)-Induced mouse model of non-alcoholic steatohepatitis (NASH)","volume":"43","author":"Yasuda","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrep.2026.102552_bib29","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/liv.13634","article-title":"Dual PPAR\u03b1\/\u03b3 agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models","volume":"38","author":"Jain","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.bbrep.2026.102552_bib30","doi-asserted-by":"crossref","first-page":"G51","DOI":"10.1152\/ajpgi.00110.2024","article-title":"Characterization of six clinical drugs and dietary intervention in the nonobese CDAA-HFD mouse model of MASH and progressive fibrosis","volume":"328","author":"Nielsen","year":"2025","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbrep.2026.102552_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75492-w","article-title":"Effects of long-term hydrogen intervention on the physiological function of rats","volume":"10","author":"Xun","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2026.102552_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.13385","article-title":"Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase-4 inhibitor on hepatic fibrosis","volume":"49","author":"Shimozato","year":"2019","journal-title":"Hepatol. Res."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:46:06Z","timestamp":1781739966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"alternative-id":["S2405580826001123"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102552","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silicon-based agent mitigates fatty liver formation in a CDAHFD60-induced MASH mouse model by enhancing hepatic function","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102552"}}